IceCure Medical Ltd. announced it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application titled "Cryogen Flow Control." This innovation is designed to enhance the efficiency of cryoablation procedures by utilizing sensor data to regulate cryogen flow, ensuring precise temperature control for improved treatment effectiveness. The patent, once granted, will be valid until 2045. This development represents a significant step in expanding IceCure's intellectual property assets and advancing its cryoablation technology.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO05760) on June 09, 2025, and is solely responsible for the information contained therein.